Who founded Engage Therapeutics?

Engage Therapeutics was founded by Gregory Mayes in 2016.

Who are Engage Therapeutics's investors?

Engage Therapeutics's investors include LifeSci Venture Partners, Lumira Ventures, Red Tree Venture.

How much funding has Engage Therapeutics raised?

Engage Therapeutics has disclosed $30.6M raised across 2 rounds.

Where is Engage Therapeutics headquartered?

Engage Therapeutics is headquartered in Summit, US.

Engage Therapeutics

Summit, US · Founded 2016 · Delaware corporation · 3 known investors

Find your way into Engage Therapeutics

Paths you didn't know you had: your email and LinkedIn already hold routes to the Engage Therapeutics team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Company whose formation and launch the LifeSci team supported.

Biotech Healthtech

Founders & leadership

Engage Therapeutics was founded in 2016 by Gregory Mayes.

Gregory MayesFounder

Jouko IsojarviNamed on SEC filing

Stephen D. CollinsNamed on SEC filing

Warren Lammert Member Board Of Directors2017–2020Founder at Tevard Biosciences

Orrin DevinskyNamed on SEC filing

Board

Gerry Brunk Board of Directors2017–2020Managing Director at Lumira Ventures

Heath Lukatch Chairman Of The Board2017–2020Partner at Novo Holdings

Investors · 3

LifeSci Venture Partnerslisted by LifeSci Venture PartnersNew Yorkvia Paul Yook · inferred

How we know: LifeSci Venture Partners's portfolio page · Not right? Tell us

Lumira Ventureslisted by Lumira VenturesToronto · $1M – $10Mvia Gerry Brunk · board

How we know: Lumira Ventures's portfolio page · board seat on SEC Form D · Not right? Tell us

Red Tree VentureinferredSan Diego

How we know: board seat on SEC Form D · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$30.6M disclosed across 2 rounds · 2017–2019

▶$7MraisedOct 2019 · 18 investors · Pharmaceuticals

Rule 506(b)

Officers, directors & promoters on the filing

Heath LukatchDirector
Gerry BrunkDirector
Jouko IsojarviExecutive Officer
Orrin DevinskyDirector
Warren LammertDirector
Gregory MayesExecutive Officer, Director, Promoter
Stephen CollinsDirector
Mark TheeuwesExecutive Officer

Offering amount: $12M
Amount sold: $7M
First sale: Oct 2019
Incorporated: Corporation, Delaware, 2016
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$23.6MraisedOct 2017 · 16 investors · Pharmaceuticals

Rule 506(b)

Officers, directors & promoters on the filing

Jouko IsojarviExecutive Officer
Stephen D. CollinsDirector
Gregory MayesExecutive Officer, Director, Promoter
Gerry BrunkDirector
Heath LukatchDirector
Warren LammertDirector
Orrin DevinskyDirector

Offering amount: $23.6M
Amount sold: $23.6M
Sales commissions: $600K
Placement agents: LifeSci Capital LLC
First sale: Sep 2017
Incorporated: Corporation, Delaware, 2016
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Engage Therapeutics do?: Company whose formation and launch the LifeSci team supported.
Who founded Engage Therapeutics?: Engage Therapeutics was founded by Gregory Mayes in 2016.
Who are Engage Therapeutics's investors?: Engage Therapeutics's investors include LifeSci Venture Partners, Lumira Ventures, Red Tree Venture.
How much funding has Engage Therapeutics raised?: Engage Therapeutics has disclosed $30.6M raised across 2 rounds.
Where is Engage Therapeutics headquartered?: Engage Therapeutics is headquartered in Summit, US.